Network origin in Martijn Bax first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
AstraZeneca BV
1
| Subsidiary | 1 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Martijn Bax via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
NewAmsterdam Pharma Holding BV
 NewAmsterdam Pharma Holding BV BiotechnologyHealth Technology Part of NewAmsterdam Pharma Co. NV, NewAmsterdam Pharma Holding BV is a Dutch company that engages in research and development of transformative therapies for cardio metabolic diseases. The company is based in Naarden, the Netherlands. The company was founded in 2019 by John Jacob Pieter Kastelein. Michael H. Davidson has been the CEO of the company since 2020. NewAmsterdam Pharma Holding was acquired by Frazier Lifesciences Acquisition Corp. on November 22, 2022 for $468.74 million. | Biotechnology | Corporate Officer/Principal | |
| FRAZIER LIFESCIENCES ACQUISITION CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| Vrije Universiteit Amsterdam | College/University | Doctorate Degree |
Statistics
International
| Netherlands | 3 |
| United Kingdom | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Marc Ditmarsch | 4 |
- Stock Market
- Insiders
- Martijn Bax
- Company connections
